Premium
Factors Affecting the Serum Free Thyroxine Levels in Hospitalized Chronic Geriatric Patients
Author(s) -
Szabolcs Istvan,
Ploenes Christoph,
Beyer Mathias,
Bernard Wolfdieter,
Herrmann Jorg
Publication year - 1993
Publication title -
journal of the american geriatrics society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.992
H-Index - 232
eISSN - 1532-5415
pISSN - 0002-8614
DOI - 10.1111/j.1532-5415.1993.tb07464.x
Subject(s) - medicine , euthyroid , endocrinology , free thyroxine , hormone , gastroenterology , thyroid function
Objective: Determination of whether nonthyroidal factors affect the diagnostic value of free thyroxine estimation in geriatric patients. Design: Survey. Participants: A convenience sample of 381 non‐selected, chronic, hospitalized geriatric patients over 60 years of age (I = relatively good health; II = relatively poor health; III = bad health; subgroups “sine therapia,” ie, patients receiving no drugs that affect FT4) and 180 20–40 year old healthy persons. Measurements: Thyrotropin‐releasing hormone test; thyrotropin (TSH); free thyroxine (FT4, measured in part by two parallel methods) estimation in a screening study; and thy‐roxine‐binding globulin and thyroxine‐binding‐inhibitor activity measurements. Results: The normal FT4 ranges of the euthyroid geriatric ( n = 210) and healthy young groups were similar. In the “sine therapia” euthyroid patients, FT4 decreased with age but increase with the severity of illness. High FT4 levels with non‐suppressed TSH were more frequent in patients in poor and bad health. (I = 6/112; II = 14/140; III = 13/74; P < 0.01). The serum thyroxine‐binding‐inhibitor activity of euthyroid geriatric patients correlated with the severity of their clinical state (I = 6.22 ± 5.65 (13); II = 7.40 ± 4.33 (23); III = 10.04 ± 5.50 (16) μg merthiolate equivalent/μL; ANOVA with log‐transformed values: F (2.51) = 3.50, P < 0.05). The mean FT4 was higher in 36 heparin‐treated patients (22.81 ± 4.67 pmol/L) than in the 193 “sine therapia” patients (19.03 ± 4.23 pmol/L; ‐ P < 0.001). In a convenience subsample of 240 patients, a weak inverse correlation was found between FT4 and the thyroxine‐binding globulin ( r = −0.14, P < 0.02). Only 5/11 patients with low free thyroxine had hypothyroidism, while 11/46 patients with elevated free thyroxine had hyperthyroidism. Conclusions: There is no need to modify the normal free thyroxine range for hospitalized geriatric patients. Clinical condition, drug treatment, and, to a lesser extent, age are factors that significantly affect the diagnostic value of FT4 in hospitalized chronic geriatric patients, decreasing the specificity of the test in diagnosing clinical hyper‐ and hypothyroidism.